Year archive

Onconic Therapeutics Inc. — 2026 filings

All 34 regulatory filings released by Onconic Therapeutics Inc. (476060) in 2026, sourced directly from the official regulator.

34 Filings

2026 Period

2026 filings (34)

Filing	Released	Lang
투자판단관련주요경영사항(임상시험계획변경승인신청) (자큐보구강붕해정(JLP2302)(자스타프라잔시트르산염)의 비위관투여 시 약동학 및 안전성 비교평가를 위한 제1상 임상시험계획승인(변경승인)신청) Regulatory Filings	2026-05-11	Korean
분기보고서 (2026.03) Interim / Quarterly Report Q1 2026	2026-05-11	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Regulatory Filings	2026-05-06	Korean
기업설명회(IR)개최 Investor Presentation	2026-04-22	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-17	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-17	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-14	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-13	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-10	Korean
투자판단관련주요경영사항(임상시험계획변경승인신청) (자큐보정(JP-1366)의 미란성 위식도역류질환 치료 후 유지요법에 대한 제3상 임상시험) Regulatory Filings	2026-03-31	Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2026-03-23	Korean
주식매수선택권부여에관한신고 Transaction in Own Shares	2026-03-23	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2026-03-23	Korean
감사보고서제출 Audit Report / Information FY 2025	2026-03-13	Korean
사업보고서 (2025.12) Annual Report FY 2025	2026-03-13	Korean
투자판단관련주요경영사항(임상시험계획변경승인) (네수파립(JPI547)의 음식물 영향 및 인종 간 차이 확인을 위한 제1상 임상시험계획승인(변경승인)) Regulatory Filings	2026-03-09	Korean
주주총회소집결의 Proxy Solicitation & Information Statement	2026-03-06	Korean
주주총회소집공고 Proxy Solicitation & Information Statement	2026-03-06	Korean
의결권대리행사권유참고서류 Proxy Solicitation & Information Statement	2026-03-06	Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동 Regulatory Filings	2026-03-06	Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동 Regulatory Filings	2026-03-06	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2026-03-04	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-02-26	Korean
영업실적등에대한전망(공정공시) Earnings Release FY 2025	2026-02-05	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Management Reports	2026-02-02	Korean
투자판단관련주요경영사항(임상시험계획변경승인) (네수파립(JPI-547)의 난소암 제2상 임상시험계획승인(변경승인)) Regulatory Filings	2026-01-20	Korean
임원ㆍ주요주주특정증권등거래계획보고서 Director's Dealing	2026-01-19	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-19	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-15	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2026-01-12	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-09	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-09	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-06	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-06	Korean